You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
|
---|---|
Published in |
Blood, September 2017
|
DOI | 10.1182/blood-2017-05-785683 |
Pubmed ID | |
Authors |
Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe, Nicole Prutsch, Lukas Kazianka, Sinan Gültekin, Gregor Hoermann, Marius E Mayerhoefer, Georg Hopfinger, Alexander Hauswirth, Michael Panny, Marie-Bernadette Aretin, Bernadette Hilgarth, Wolfgang R Sperr, Peter Valent, Ingrid Simonitsch-Klupp, Richard Moriggl, Olaf Merkel, Lukas Kenner, Ulrich Jäger, Stefan Kubicek, Philipp B Staber |
X Demographics
The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6 | 19% |
Spain | 3 | 10% |
Canada | 1 | 3% |
Germany | 1 | 3% |
United Kingdom | 1 | 3% |
Ireland | 1 | 3% |
Austria | 1 | 3% |
Australia | 1 | 3% |
Unknown | 16 | 52% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 21 | 68% |
Scientists | 5 | 16% |
Science communicators (journalists, bloggers, editors) | 4 | 13% |
Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 90 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 14 | 16% |
Researcher | 14 | 16% |
Student > Ph. D. Student | 12 | 13% |
Student > Master | 8 | 9% |
Student > Bachelor | 7 | 8% |
Other | 17 | 19% |
Unknown | 18 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 37% |
Biochemistry, Genetics and Molecular Biology | 14 | 16% |
Agricultural and Biological Sciences | 9 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Chemistry | 2 | 2% |
Other | 7 | 8% |
Unknown | 21 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 52. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2022.
All research outputs
#826,326
of 26,017,215 outputs
Outputs from Blood
#547
of 33,954 outputs
Outputs of similar age
#16,943
of 332,459 outputs
Outputs of similar age from Blood
#19
of 238 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,954 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,459 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.